Menlo Ventures Unveils $3 Billion War Chest For The AI Investing Race
A veteran Silicon Valley investor has closed its largest capital raise ever, splitting the funds across two vehicles built to back artificial intelligence companies from their first check all the way to breakout growth.
A firm known for decades of early bets on category-defining companies has just put together its biggest pool of capital yet, and it's pointing almost all of it at artificial intelligence.
A Record-Setting Raise
The firm confirmed this week that it has pulled together $3 billion in new commitments, marking the single largest capital raise across its five-decade history. The money will be funneled into AI-focused startups spanning enterprise software, healthcare, and consumer products, giving the firm room to write checks at nearly every stage of a company's life.
Betting Early, Betting Big
The firm's boldest move to date traces back to an early wager on a frontier AI lab that has since become the most valuable of its kind in the world, having recently overtaken its best-known rival to reach a valuation near $965 billion. The investor got involved back when the startup had no product and no revenue, at a time when much of the market assumed the large-language-model race had already been decided by other players.
The firm has described that decision as its defining moment — the point where its broader AI strategy took shape. Leadership pointed to the founding team's research pedigree and clarity of vision as the reason they were confident there was still room for another independent model-building company to break through. The firm didn't stop at one check either; it went on to lead the startup's next major funding round the following year, deepening its stake in what has become its flagship success story.
A Track Record Beyond AI
Artificial intelligence may be the current headline, but the firm's history includes stakes in a well-known ride-hailing giant, a leading streaming device maker, a popular eyewear brand, an early voice-assistant technology, and a major biotech name. That breadth is part of why the firm frames its AI push not as a pivot, but as an extension of a long pattern of spotting category leaders before the rest of the market catches on.
Its marquee AI bet is also reportedly preparing for a public listing, with market chatter suggesting a valuation target of $1 trillion or more. Should that listing happen, it would represent by far the largest exit in the firm's history, dwarfing anything else currently in its portfolio.
Backing an unproven team before the rest of the market agrees is exactly the kind of conviction that can turn a single early check into a firm-defining outcome.
- A landmark raise. The $3 billion pool is the largest the firm has ever assembled in its five decades of investing.
- Two funds, two stages. One vehicle targets seed and Series A startups, while the other focuses on growth-stage companies already pulling ahead.
- An early AI conviction paid off. A pre-revenue bet on a frontier AI lab became the firm's most valuable investment by far.
- Sector-agnostic ambitions. The new capital is aimed at enterprise, healthcare, and consumer AI companies, not just one niche.
- A potential record exit looms. A rumored trillion-dollar-plus public listing for its top holding could become the firm's biggest payday yet.